DFPQ is a powerful and selective beta-arrestin-biased negative allosteric modulator(NAM) targeting the beta2-adrenergic receptor. It specifically inhibits the interaction of beta-arrestin with beta2AR without altering beta-agonist-induced cAMP production. Additionally, DFPQ reduces functional desensitization of the beta2AR in airway smooth muscle, enhancing beta-agonists capacity to maintain bronchorelaxation and curbing cell migration during prolonged beta-agonist treatment.
Molekulargewicht:
354.4
CAS Nummer:
[911678-60-9]
Formel:
C20H20F2N4
T87969
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten